Alpha 1-antitrypsin activity is markedly decreased in Wegener’s granulomatosis
- 453 Downloads
Alpha 1-antitrypsin (A1AT) is the most abundant proteinase inhibitor in plasma and the main inhibitor of Proteinase 3, the target antigen of antineutrophil cytoplasmic antibodies (ANCAs) that predominant in Wegeners’ granulomatosis. Α1AT deficiency correlated with ANCA-associated vasculitis. This study explores the trypsin inhibitory capacity (TIC), specific activity, and phenotypic deficiency of Α1AT in Wegener’s granulomatosis. Twenty-seven WG patients were studied. ANCA was tested by IIF and ELISA. Serum a1-anti-trypsin levels were quantified in WG patients and healthy controls by immunoturbidimetric assay. Serum TIC was assessed by the enzymatic colorimetric assay. Phenotypes of A1AT were detected by Isoelectric Focusing. A1AT concentration was equivalent in patients and controls; however, serum TIC (P = 0.001) and specific activity of A1AT (P = 0.001) were dramatically lower in WG patients. Five patients had deficient phenotypes of A1AT: MZ (n = 3), MS (n = 1) and SS (n = 1). This was correlated with an increase in the prevalence of deficient phenotypes of A1AT in WG (P = 0.01). Trypsin inhibitory capacity and specific activity of A1AT were decreased in WG patients and may be involve in disease pathogenesis and can worsen the clinical manifestations. This A1AT deficiency probably resulted from oxidative inactivation and/or enzymatic degradation of A1AT. This could result in localized deficiency of A1AT in vessel wall interfaces and lead to severe disease.
KeywordsAlpha 1-antitrypsin Antineutrophil cytoplasmic antibody Proteinase 3 Wegener’s granulomatosis
We would like to thank Rheumatology Research Center for technical assistance. This study was supported by Tarbiat Modares University.
Conflict of interest
The authors declare no potential conflicts of interest.
- 9.Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, Dellaripa PF, Seo P, Spiera RF, Rouhani FN, Brantly ML, Merkel PA, Granulomatosis Genetic Repository Research G (2010) Alpha1-antitrypsin deficiency–related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum 62:3760–3767PubMedCentralPubMedCrossRefGoogle Scholar
- 10.Morris H, Morgan MD, Wood AM, Smith SW, Ekeowa UI, Herrmann K, Holle JU, Guillevin L, Lomas DA, Perez J, Pusey CD, Salama AD, Stockley R, Wieczorek S, McKnight AJ, Maxwell AP, Miranda E, Williams J, Savage CO, Harper L (2011) ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers. Ann Rheum Dis 70:1851–1856PubMedCrossRefGoogle Scholar
- 11.Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107PubMedCrossRefGoogle Scholar
- 12.Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, Es LAV, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192PubMedCrossRefGoogle Scholar
- 13.Dietz AA, Rubinstein HM, Hodges L (1974) Measurement of Alpha1-antitrypsin in serum, by immunodiffusion and by enzymatic assay. Clin Chem 20:396–399Google Scholar
- 26.Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AEGK, Kallenberg CGM, Goldschmeding R (1993) Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-α1-antitrypsin complexation to disease activity in Wegener’s granulomatosis. Clin Exp Immunol 93:405–410PubMedCentralPubMedCrossRefGoogle Scholar